Patent · US Active

Wetting agent formulation

US11524096B2 · kind B2 · utility

0Cited by
9References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2017
Grant dateDec 13, 2022
Priority date
Expiry dateNov 20, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08K5/1345
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A first alternative to a composition for preventing or retarding degradation of a functional coating on a medical device includes an antioxidant selected from gallic acid or a derivative thereof. A second alternative to a composition for preventing or retarding degradation of a functional coating on a medical device includes carboxymethyl cellulose or a derivative or salt thereof. The use of the compositions for preventing or retarding degradation of a functional coating on a medical device from reactive species generated during exposure of radiation, and a wetting agent comprising the compositions, are also provided. The wetting agent prevents or retards the hydrolytic degradation of the coating during the intended shelf-life of the wetted coated product.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.